Royalty Pharma plc (RPRX)

Finanzdaten der Royalty Pharma plc-Aktie (RPRX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.14% 596.07	536.31	538.20	683.97	565.75
Operating Expenses	104.37% -16.83	384.87	289.36	205.00	1,048.40
Interest Income/Expense	2.65% 47.26	46.03	46.95	46.95	46.95
Benefits Costs and Expenses	129.34% -121.52	414.24	186.87	174.88	1,175.78
Costs And Expenses	104.37% -16.83	384.87	289.36	205.00	1,048.40
Provision For Loan, Lease, And Other Losses	130.49% -9.12	29.91	-5.922	7.415	-312.37
Operating Income/Loss	304.71% 612.90	151.44	248.84	478.97	-482.65
Nonoperating Income/Loss	456.51% 104.69	-29.36	102.50	30.12	-127.38
Income/Loss Before Equity Method Investments	463.49% 717.32	127.30	352.11	474.48	-603.17
Income/Loss From Equity Method Investments	105.13% 0.268	-5.222	-0.77	34.61	-6.856
Income/Loss From Continuing Operations Before Tax	487.81% 717.59	122.08	351.34	509.09	-610.03
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	487.81% 717.59	122.08	351.34	509.09	-610.03
Net Income/Loss	487.81% 717.59	122.08	351.34	509.09	-610.03
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	346.82% 223.25	49.96	123.71	168.33	-153.95
Basic Average Shares	100.13% -0.561	448.44	450.40	445.61	1.421
Diluted Average Shares	100.30% -1.817	601.14	605.86	607.25	-169.24
Basic Earnings Per Share	593.75% 1.11	0.16	0.51	0.76	-1.04
Diluted Earnings Per Share	587.50% 1.10	0.16	0.50	0.76	-1.04
Common Stock Dividends	0.00% 0.20	0.20	0.20	0.20	0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-